About Benchling
Benchling is an IT company that provides a cloud-based software platform for biology researchers and research and development organizations.
Headquarters
Benchling, San Francisco
Founded
2012-01-01
Industry
Biotechnology, Life Science, Software
Last Funding Type
Series F
Valuation
37
Total Funding
$411.90 million dollars
IPO Status
Private
Financial
Benchling is engaged in developing tools for molecular sequence design, enabling automatic generation of molecular constructs through user interface presentations. They are also advancing methods for searching chemical structures, facilitating the identification of molecules and compounds. Additionally, Benchling is enhancing molecular databases by updating target molecule components and visualizing synthetically-modified nucleotide sequences. These efforts are complemented by a machine learning research platform that optimizes life sciences experiments, underscoring their focus on innovative solutions for biology research.
Funding Rounds
9
Number of Lead Investors
8
Total Funding Amount
$411.90 million dollars
Number of Investors
23